A New Decade Of Outsourcing: What Can We Expect?

Source: Outsourced Pharma

Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.

Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."

Our esteemed panel included Darren Dasburg, (former) VP & Head Learning and Development Global Operations | AstraZeneca, Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain | ImmunoGen, Praveen Prasanna, Sr. Director, Technical Operations | AVEO Oncology, Jana Spes, Head of Pharmaceutical Development & Manufacturing Sciences | Ironwood Pharmaceuticals, and Mark Butchko, Sr. Director, Quality Assurance - Development | Lilly and Company.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma